Società KetamineOne Capital Deutsche Boerse AG
Azioni
MY00
CA4925531028
Prestatari di assistenza sanitaria
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Najla Guthrie
CEO | Chief Executive Officer | - | 01/06/21 |
Terry Zimaro
DFI | Director of Finance/CFO | 49 | 15/06/22 |
Keith White
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/21 |
Natalie Dolphin
IRC | Investor Relations Contact | - | 21/06/22 |
Andrew Charrette
LAW | General Counsel | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Brendan Purdy
BRD | Director/Board Member | 37 | 07/01/21 |
Najla Guthrie
CEO | Chief Executive Officer | - | 01/06/21 |
Natasha Raey
BRD | Director/Board Member | 42 | 18/09/20 |
Mohammad Sharifi
BRD | Director/Board Member | - | 22/11/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 129 971 885 | 129 971 885 ( 100,00 %) | 0 | 100,00 % |
Coordinate società
Wellbeing Digital Sciences, Inc.
275 Dundas Street Unit A1605
N6B 3L1, London
+
http://www.wellbeingdigital.co![Indirizzo KetamineOne Capital(MY00)](https://cdn.zonebourse.com/static/address/111482985.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+18,33% | 83,89 Mrd | |
-28,29% | 71,08 Mrd | |
+1,34% | 26,77 Mrd | |
+3,67% | 17,74 Mrd | |
-9,99% | 17,24 Mrd | |
+1,86% | 15,6 Mrd | |
+79,98% | 13,84 Mrd | |
-25,09% | 12,92 Mrd | |
+74,41% | 12,87 Mrd |